Publications by authors named "Alice Iezzi"

Claim this Profile
M
Molecular determinants of response to PI3K/akt/mTOR and KRAS pathways inhibitors in NSCLC cell lines.
Alice Iezzi, Elisa Caiola, Marika Colombo, Mirko Marabese, Massimo Broggini

Am J Cancer Res· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors.
Elisa Caiola, Alice Iezzi, Michele Tomanelli, Elisa Bonaldi, Arianna Scagliotti

J Thorac Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation and characterization of MEK and ERK inhibitors- resistant non-small-cells-lung-cancer (NSCLC) cells.
Alice Iezzi, Elisa Caiola, Arianna Scagliotti, Massimo Broggini

BMC Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wee1 inhibitor MK1775 sensitizes KRAS mutated NSCLC cells to sorafenib.
Elisa Caiola, Roberta Frapolli, Michele Tomanelli, Rossana Valerio, Alice Iezzi

Sci Rep· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity of Pan-Class I Isoform PI3K/mTOR Inhibitor PF-05212384 in Combination with Crizotinib in Ovarian Cancer Xenografts and PDX.
Alice Iezzi, Elisa Caiola, Massimo Broggini

Transl Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis